Utama › Tumor Otak › Texas › Houston
Kajian klinikal Tumor Otak di Houston, TX
35 kajian untuk Tumor Otak sedang mencari peserta di lokasi dalam dan sekitar Houston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
Mengambil pesertaFasa 1
- Baylor St. Luke's Medical Center, Houston
Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)
Mengambil pesertaFasa 2
- The University of Texas M. D. Anderson Cancer Center, Houston
A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
Mengambil pesertaFasa 2
- M D Anderson Cancer Center, Houston
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Mengambil pesertaFasa 1/2
- MD Anderson Cancer Center, Houston
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Mengambil pesertaFasa 2
- Local Institution - 0085, Houston
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Mengambil pesertaFasa 2
- Texas Children's Hospital, Houston
OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
Mengambil pesertaKajian pemerhatian
- M D Anderson Cancer Center, Houston
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Mengambil pesertaFasa 1
- MD Anderson Cancer Center - University of Texas, Houston
A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers
Mengambil pesertaKajian pemerhatian
- MD Anderson Cancer Center, Houston
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Mengambil pesertaFasa 1/2
- University of Texas MD Anderson Cancer Center, Houston
Targeted Pediatric High-Grade Glioma Therapy
Mengambil pesertaKajian pemerhatian
- Texas Children's Hospital, Houston
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
Mengambil pesertaFasa 2
- UT MD Anderson Cancer Center, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
Study of Olutasidenib and Temozolomide in HGG
Mengambil pesertaFasa 2
- Texas Children's Hospital, Houston
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Mengambil pesertaFasa 2
- MD Anderson Cancer Center, Houston
A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases
Mengambil pesertaFasa 1
- The University of Texas M.D. Anderson Cancer Center, Houston
Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
Mengambil pesertaFasa 2
- Houston Methodist Neal Cancer Center, Houston
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
Mengambil pesertaFasa 1
- Excel Diagnostics & Nuclear Oncology Center, Houston
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Mengambil pesertaFasa 1
- Texas Children's Hospital, Houston
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Mengambil pesertaKajian pemerhatian
- Baylor St. Luke's Medical Center | Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
Mengambil pesertaFasa 1
- M D Anderson Cancer Center, Houston
A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)
Mengambil pesertaFasa 2
- M D Anderson Cancer Center, Houston
Mapping of Human Cognition
Mengambil peserta
- The University of Texas Health Science Center at Houston, Houston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Mengambil pesertaFasa 2
- Texas Children's Hospital, Houston
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Mengambil peserta
- M D Anderson Cancer Center, Houston
A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
Mengambil pesertaKajian pemerhatian
- M D Anderson Cancer Center, Houston
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
Mengambil pesertaFasa 2
- M D Anderson Cancer Center, Houston
EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active
Mengambil pesertaFasa 2
- The University of Texas MD Anderson Cancer Center, Houston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Mengambil pesertaFasa 1/2
- MD Anderson Cancer Center, Houston
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Mengambil pesertaKajian pemerhatian
- Md Anderson Cancer Center, Houston
Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)
Mengambil pesertaFasa 2
- M D Anderson Cancer Center, Houston
Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors
Mengambil peserta
- MD Anderson Cancer Center, Houston
Systematic Light Exposure in Pediatric Brain Tumor Survivors
Mengambil peserta
- Texas Children's Hospital, Houston
A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
Mengambil pesertaFasa 1/2
- MD Anderson, Houston
Kajian Tumor Otak di bandar lain
- Boston, MA28 kajian
- New York City, NY25 kajian
- Washington, DC20 kajian
- Los Angeles, CA16 kajian
- Miami, FL15 kajian
- Durham, NC14 kajian
- St. Louis, MO12 kajian
- Cleveland, OH11 kajian
- Seattle, WA11 kajian
- Rochester, MN11 kajian
- Baltimore, MD11 kajian
- Columbus, OH11 kajian
Kajian lain di Houston
- Kanser Paru-paru Bukan Sel Kecil145 kajian
- Kanser Payudara126 kajian
- Kanser (semua jenis)121 kajian
- Kanser Metastatik104 kajian
- Kanser Kolorektal102 kajian
- Kanser Ovari89 kajian
- Leukemia Mieloid Akut85 kajian
- Kanser Paru-paru78 kajian
- Kanser Prostat76 kajian
- Kanser Endometrium68 kajian
- Kanser Pankreas61 kajian
- Melanoma59 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.